These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 411767)

  • 1. The immune response in acute myelocytic leukemia: effect of the methanol extraction residue fraction of tubercle bacilli (MER) on T and B cell functions and their relation to the course of the disease.
    Izak G; Stupp Y; Manny N; Zajicek G; Weiss DW
    Isr J Med Sci; 1977 Jul; 13(7):677-93. PubMed ID: 411767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular immunity indices in acute leukemia in a period of remission].
    Miterev GIu; Samoĭlova RS; Bulycheva TI; Kovaleva LG; Maiakova SA
    Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):28-34. PubMed ID: 311002
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
    Moertel CG; Ritts RE; Schutt AJ; Hahn RG
    Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indicators of cellular immunity and the incidence of infectious-inflammatory diseases during clinico-hematological remission in patients with acute leukemia].
    Vinogradova IuE; Ivanina EK
    Ter Arkh; 1984; 56(6):46-50. PubMed ID: 6332389
    [No Abstract]   [Full Text] [Related]  

  • 5. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of active immunotherapy of acute myeloid leukemia.
    Mathé G; Musset M; Schwarzenberg L; Hayat M; de Vassal F; Amiel JL; Pouillart P; Misset JL
    Biomedicine; 1975 Sep; 23(7):291-3. PubMed ID: 1066168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of lymphocyte subpopulations during the remission-maintaining treatment of patients with myeloblastic leukemia].
    Duraj M; Hołowiecki J; Krawczyk M; Rudzka E; Jagoda K
    Acta Haematol Pol; 1987; 18(1-2):28-34. PubMed ID: 3501662
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immune reactions in human acute leukemia.
    Herberman RB
    Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of the immunologic response in the formation of the clinical picture of hepatitis B].
    Deroń Z
    Pol Tyg Lek; 1984 Aug; 39(33):1107-10. PubMed ID: 6334281
    [No Abstract]   [Full Text] [Related]  

  • 10. T-cell qualities of lymphocytes and/or leukemic cells from peripheral blood in acute myeloid and lymphatic leukemia before treatment and at relapse.
    de Vaan GA; Bakkeren JA; Schretlen ED
    Biomedicine; 1975 Nov; 22(6):524-31. PubMed ID: 1083749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
    Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
    J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress and problems in the treatment of acute myeloid leukemia: analysis of 92 cases].
    Ruggero D; Baccarani M; Tomasini I; Gobbi M; Santucci MA; Guarini A; Tura S
    G Clin Med; 1976; 57(9-10):283-97. PubMed ID: 1072018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents].
    Urasiński I; Proniewska M; Schumacher K
    Acta Haematol Pol; 1979; 10(2):129-36. PubMed ID: 314215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
    Arends-Merino A; Sjögren AM; Reizenstein P
    Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spontaneous autorosette formation indices in acute leukemia].
    Mazurenko VA
    Vrach Delo; 1981 Jul; (7):42-6. PubMed ID: 6974430
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immune response during specific hyposensitization in atopic asthma patients.
    Moniuszko T; Chyrek-Borowska S; Moniuszko C
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):375-80. PubMed ID: 6335958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 18. Cowden's disease associated with immunodeficiency.
    Ruschak PJ; Kauh YC; Luscombe HA
    Arch Dermatol; 1981 Sep; 117(9):573-5. PubMed ID: 6975083
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic effectiveness of neuraminidase-treated allogeneic myeloblasts as immunogen in acute myelocytic leukemia.
    Bekesi JG; Holland JF
    Recent Results Cancer Res; 1982; 80():42-55. PubMed ID: 6800000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of alcohol on the lymphocyte system. V. Evaluation of blast transformation and rosette formation of peripheral blood lymphocytes in alcoholics].
    Pietruczuk M; Dabrowska M; Wołosowicz N; Hryniewicz K
    Przegl Lek; 1990; 47(4):389-93. PubMed ID: 2217854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.